These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 33004602)

  • 1. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
    Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
    JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
    Bernard-Valnet R; Perriot S; Canales M; Pizzarotti B; Caranzano L; Castro-Jiménez M; Epiney JB; Vijiala S; Salvioni-Chiabotti P; Anichini A; Salerno A; Jaton K; Vaucher J; Perreau M; Greub G; Pantaleo G; Du Pasquier RA
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34135107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
    Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
    J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
    Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
    Cunningham JL; Virhammar J; Rönnberg B; Dopico XC; Kolstad L; Albinsson B; Kumlien E; Nääs A; Klang A; Westman G; Zetterberg H; Frithiof R; Lundkvist Å; Karlsson Hedestam GB; Rostami E
    J Infect Dis; 2022 Mar; 225(6):965-970. PubMed ID: 33744954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesis.
    Edén A; Simrén J; Price RW; Zetterberg H; Gisslén M
    J Neurochem; 2021 Oct; 159(1):61-77. PubMed ID: 34170549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
    Lersy F; Benotmane I; Helms J; Collange O; Schenck M; Brisset JC; Chammas A; Willaume T; Lefebvre N; Solis M; Hansmann Y; Fabacher T; Caillard S; Mertes PM; Pottecher J; Schneider F; Meziani F; Fafi-Kremer S; Kremer S
    J Infect Dis; 2021 Feb; 223(4):600-609. PubMed ID: 33249438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens.
    Neu F; Nay S; Schuchardt S; Klawonn F; Skripuletz T; Suehs KW; Pessler F
    J Transl Med; 2024 Jul; 22(1):620. PubMed ID: 38961383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the Diagnosis of SARS-CoV-2 Infection in the Nervous System.
    Da Silva SJ; Cabral-Castro MJ; Gonçalves CCA; Mariani D; Ferreira O; Tanuri A; Puccioni-Sohler M
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
    Peluso MJ; Sans HM; Forman CA; Nylander AN; Ho HE; Lu S; Goldberg SA; Hoh R; Tai V; Munter SE; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Martin JN; Kelly JD; Durstenfeld MS; Hsue PY; Hunt PW; Greene M; Chow FC; Hellmuth J; Henrich TJ; Glidden DV; Deeks SG
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35701186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
    Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
    J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.
    Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M
    Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.
    Pilotto A; Masciocchi S; Volonghi I; De Giuli V; Caprioli F; Mariotto S; Ferrari S; Bozzetti S; Imarisio A; Risi B; Premi E; Benussi A; Focà E; Castelli F; Zanusso G; Monaco S; Stefanelli P; Gasparotti R; Zekeridou A; McKeon A; Ashton NJ; BlennoW K; Zetterberg H; Padovani A
    Clin Infect Dis; 2021 Nov; 73(9):e3019-e3026. PubMed ID: 33395482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 Patients.
    Zingaropoli MA; Iannetta M; Piermatteo L; Pasculli P; Latronico T; Mazzuti L; Campogiani L; Duca L; Ferraguti G; De Michele M; Galardo G; Pugliese F; Antonelli G; Andreoni M; Sarmati L; Lichtner M; Turriziani O; Ceccherini-Silberstein F; Liuzzi GM; Mastroianni CM; Ciardi MR
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
    Kanberg N; Grahn A; Stentoft E; Bremell D; Yilmaz A; Studahl M; Nilsson S; Schöll M; Gostner JM; Blennow K; Zetterberg H; Padmanabhan N; Cohen R; Misaghian S; Romero D; Campbell C; Mathew A; Wang M; Sigal G; Stengelin M; Edén A; Gisslén M
    J Infect Dis; 2024 Feb; 229(2):493-501. PubMed ID: 37874918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.
    Bartley CM; Johns C; Ngo TT; Dandekar R; Loudermilk RL; Alvarenga BD; Hawes IA; Zamecnik CR; Zorn KC; Alexander JR; Wapniarski AE; DeRisi JL; Francisco C; Nash KB; Wietstock SO; Pleasure SJ; Wilson MR
    JAMA Neurol; 2021 Dec; 78(12):1503-1509. PubMed ID: 34694339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.